Monthly Archives: March 2009

From the Wall St. Journal: Coming Soon: Comparative Effectiveness Research for Biotech Which treatment works best for a given medical condition? The big stimulus package includes $1.1 billion in funding for so-called “comparative-effectiveness” research aimed at answering that question. Now … Continue reading →

From the New Scientist: Special investigation: How my genome was hacked INTIMATE secrets hidden in your DNA could be stolen without you even realising. By taking a glass from which you have drunk, a “genome hacker” could obtain a comprehensive … Continue reading →

I assume this is a spoof. Here’s what is supposedly the website for CyClone Dairy (a dairy that claims that 100% of its milk comes from cloned cows). If anyone knows who’s behind this, email me.

From the Tyee: Salmon Genes, Discuss Fish is not something that usually makes us tense, but we didn’t know what to expect. We had invited 26 regular B.C. folk to Vancouver to discuss their hopes and concerns for sequencing the … Continue reading →

Quick comment & question: The biotech industry (& biotech research more generally) has 3 main areas: health biotech (new drugs, stem cell research, etc.)food biotech (GM crops, GM aquaculture, etc.)industrial biotech (using microbes & enzymes in manufacturing or, for example, … Continue reading →

From UC Davis News & Information: U.S.-Brazilian Research Team to Tackle Deadly Intestinal Diseases with Genetically Enhanced Goats’ Milk Scientists in Brazil and at the University of California, Davis, are teaming up to develop a herd of genetically modified dairy … Continue reading →

From the International Herald Tribune: A new push to win EU acceptance for biotechFirst few paragraphs… The biotechnology industry, claiming the backing of European Union governments, signaled a new effort Monday to win greater leeway to grow genetically modified crops … Continue reading →

Here’s an editorial from the American Enterprise Institute for Public Policy Research: Stem Cells and the Truth About Medical InnovationFirst few paragraphs… Whatever one thinks of the ethics of using human embryos in medical research, the rhetoric around President Barack … Continue reading →

From Reuters: US lawmakers propose generic biotech drug plan U.S. lawmakers unveiled a bipartisan proposal on Wednesday to allow government approval for cheaper copies of biotechnology medicines that cost as much as tens of thousands of dollars per year. Representative … Continue reading →

Biotech ethics isn’t all science ethics. This story is about fair treatment of shareholders. From the San Jose Mercury News: A biotech firm taking a chance on a reverse merger It is called a reverse merger. And for a failing … Continue reading →